AI Diagnostics:
WiseNetra

Artificial intelligence (AI) is on the verge of revolutionizing the healthcare industry that will significantly change the culture of healthcare delivery and medical diagnosis making healthcare more affordable and accessible. As a subset of AI, Machine Learning (ML) technology identifies patterns, uses algorithms and data to give automated insights to healthcare professionals in their clinical decision making. 

With the recent success stories of AI in diagnosis of breast cancer and other chronic diseases (https://www.bbc.com/news/health-50857759), AI continues to win the confidence of physicians in identifying medical diagnosis and has become a more viable source of diagnostic information. 

As an Artificial Intelligence (AI) based healthcare tech company, Wiseyak has developed a robust data-driven Clinical Decision Support System (CDSS) for physicians and healthcare professionals. Using Deep Learning model based on 30,000 retinal images, Wiseyak has developed an AI-based application for Diabetic Retinopathy (DR), namely WiseNetra. DR is an eye disease known to cause moderate to severe visual loss and is the leading cause of blindness in working-age people suffering with long standing diabetes. 

WiseNetra application installed in fundus cameras (mydriatic or non-mydriatic) performs retinopathy screening of patients. Following retinal screening, WiseNetra automatically recognizes the specific patterns existed in retina and helps ophthalmologists to make necessary clinical decisions. Such AI-based applications are not only reliable but also makes healthcare more affordable and accessible to the rural communities where there are no or very limited healthcare resources. 

In addition to WiseNetra, Wiseyak is also in the process of developing other medical diagnosis applications including AI-based breast cancer diagnosis and digital pathology applications.

 

Wiseyak AI-Diagnostics: 

WiseEye

Upcoming Products→ Cancer Diagnosis      

WiseEye

WiseEye is a software product using Artificial Intelligence to analyze color fundus images for presence of Diabetic Retinopathy (DR). WiseEye makes real-time DR screening possible by assisting ophthalmologists to quickly and accurately identify DR patients.

 

How is works

As simple as 1,2,3

Step 1

Capture fundus image of patient’s eye

Step 2

WiseEye reads the image

Step 3

WiseEye reads the image

Benefits

  • Easy to use

Any fundus camera (including ones that can be attached to a phone) can be used to take the picture and submit it to WiseEye for analysis.

  • Instant screening 

The report is generated within a couple of minutes after the submission of the patient’s images. 

  • Reduced workload and efficiency

Timely identification of possible DR saves valuable time and resources for both patients and ophthalmologists.

Ravi Bajracharya

Co-Founder
CTO

Ravi Bajracharya is a passionate IT entrepreneur and Chief Technology Officer (CTO) of Wiseyak. Ravi specializes in healthcare informatics and ontologies. He has over 10 years of experience in software design and development. He has worked various industries including fin-tech and online marketing.